![Small molecule neuropilin-1 antagonists combine anti-angiogenic and anti-tumour activity with immune modulation through reduction of transforming growth factor beta (TGFβ) production in regulatory T-cells]()
Small molecule neuropilin-1 antagonists combine anti-angiogenic and anti-tumour activity with immune modulation through reduction of transforming growth factor beta (TGFβ) production in regulatory T-cellsPowell, Jonathan; Mota, Filipa; Steadman, David; Soudy, Christelle; Miyauchi, Jeremy T; Crosby, Stuart; Jarvis, Ashley; Reisinge, Tifelle; Winfield, Natalie; Evans, Graham; Finniear, Aled; Yelland, Tamas; Chou, Yi-Tai; Chan, A.W. Edith; O'Leary, Andrew; Cheng, Lili; Liu, Dan; Fotinou, Ntina; Milagre, Carla; Martin, John F; Jia, Haiyan; Frankel, Paul; Djordjevic, Snezana; Tsirka, Stella E; Zachary, Ian C.; Selwood, David L · Journal of Medicinal Chemistry · 2018